Rationale and design of the EMPERIAL‐Preserved and EMPERIAL‐Reduced trials of empagliflozin in patients with chronic heart failure by Abraham, William T., Ponikowski, Piotr, Brueckmann, Martina, Zeller, Cordula, Macesic, Hemani, Peil, Barbara, Brun, Michèle, Ustyugova, Anastasia, Jamal, Waheed, Salsali, Afshin, Lindenfeld, JoAnn, Anker, Stefan D., Abraham, William, Anker, Stefan, Lindenfeld, JoAnn, Ponikowski, Piotr, Brueckmann, Martina, Salsali, Afshin, Welty, Francine, Clayton, Tim, Greenberg, Barry, Konstam, Marvin, Lees, Kennedy, Palmer, Mike, Parhofer, Klaus, Pedersen, Terje, Carson, Peter, Freston, James, Kaplowitz, Neil, Lewis, James, Mann, Johannes, Petrie, John, Agostoni, Piergiuseppe, Butler, Javed, Desai, Akshay, Filippatos, Gerasimos, Howlett, Jonathan, Wranicz, Jerzy, Mas, Josep Redón, Cardoso, José Silva, Störk, Stefan

Get full text